Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jul;37(5):452-460.
doi: 10.1007/s10875-017-0401-y. Epub 2017 May 18.

Advances in the Care of Primary Immunodeficiencies (PIDs): from Birth to Adulthood

Affiliations
Review

Advances in the Care of Primary Immunodeficiencies (PIDs): from Birth to Adulthood

Nizar Mahlaoui et al. J Clin Immunol. 2017 Jul.

Abstract

Primary immunodeficiencies (PIDs) are a widely heterogeneous group of inherited defects of the immune system consisting of many clinical phenotypes with at least 300 underlying genetic deficits currently known. Patients with PIDs can present with, or develop during the course of their life, a susceptibility to recurrent and chronic infection along with autoimmune, allergic, inflammatory, and/or proliferative disorders, all potentially leading to end-organ damage. In recent years, a combination of basic and clinical research has greatly improved understanding of the underlying immunological and genetic defects in PIDs, leading to improved diagnosis, classification, and treatment approaches. In this review, we consider some of the key understandings that should direct diagnostic and treatment approaches in PID and offer insights into current and emerging management approaches and the lifelong care of patients from childhood through to adulthood.

Keywords: Primary immunodeficiency; continuity of care; diagnosis; management; reference centers/networks; teenagers; transfer clinic; transition care; young adults.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
The three key diagnostic aspects of immunodeficiency to consider in CVID
Fig. 2
Fig. 2
The overlap and interconnectivity of states in which immune dysfunction plays a part in disease pathology (image devised by A. Cant)
Fig. 3
Fig. 3
An example of a transition algorithm (courtesy of S. Workman)

References

    1. Picard C, Al-Herz W, Bousfiha A, et al. Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015. J Clin Immunol 2015. - PMC - PubMed
    1. Parvaneh N, Casanova JL, Notarangelo LD, Conley ME. Primary immunodeficiencies: a rapidly evolving story. J Allergy Clin Immunol. 2013;131:314–323. doi: 10.1016/j.jaci.2012.11.051. - DOI - PubMed
    1. Fischer A, Hacein-Bey Abina S, Touzot F, Cavazzana M. Gene therapy for primary immunodeficiencies. Clin Genet. 2015;88:507–515. doi: 10.1111/cge.12576. - DOI - PubMed
    1. ESID. Database statistics. http://esid.org/Working-Parties/Registry/ESID-Database-Statistics 2016; Accessed January 2016.
    1. Picard C, Fischer A. Contribution of high-throughput DNA sequencing to the study of primary immunodeficiencies. Eur J Immunol. 2014;44:2854–2861. doi: 10.1002/eji.201444669. - DOI - PubMed

LinkOut - more resources